Table 1.
TLR | Cellular expression | Receptor complex | Natural Ligands | Synthetic Agonists | Signaling adaptor | Downstream effects |
---|---|---|---|---|---|---|
TLR2 | Plasma membrane | 2–1 2–6 2–10 |
Lipopeptides Peptidoglycan Lipoteichoic acid Zymosan Lipoarabinomannans |
Pam2Cys Pam3Cys |
MyD88 | inflammatory cytokines (TNFα, IL-1β, IL-6, IL-8, IL-10, IL-12) CD80, CD86 upregulation |
TLR3 | Endolysosome | 3–3 | dsRNA | PolyI:C PolyIC12U PolyICLC ARNAX RGC100 |
TRIF | IFNβ CXCL10 CD80, CD86 upregulation |
TLR4 | Plasma membrane | 4-MD2 | LPS | MPLA GLA ONO-4007 |
MyD88 TRIF |
inflammatory cytokines (TNFα,IL-1β,IL-6) IFNβ CXCL10 CD80, CD86 upregulation |
TLR5 | Plasma membrane | 5–5 | Bacterial flagellin | Flagellin | MyD88 | inflammatory cytokines (TNFα,IL-1β,IL-6,IL-8) CD80, CD86 upregulation |
TLR7 | Endolysosome | 7–7 | ssRNA | Resiquimod Imiquimod Vesatolimod |
MyD88 | Type 1 IFN CD80, CD86 upregulation |
TLR8 | Endolysosome | 8–8 | ssRNA | Resiquimod Selgantolimod Motolimod |
MyD88 | inflammatory cytokines (TNFα, IL-1β, IL-6, IL-8, IL-10, IL-12) CD80, CD86 upregulation |
TLR9 | Endolysosome | 9–9 | CpG-DNA | ODN-2216(Class A) ODN-2006(Class B) ODN-2429(Class C) ODN-21798(Class P) IMO-2025 IMO-2125 MGN-1703 |
MyD88 | Type 1 IFN CD80, CD86 upregulation |
TLR10 | Plasma membrane | 10–1 10–2 10–6 10–10 |
Triacylated lipopeptides | N/A | Unknown | IL-1Ra |
TLR11 | Endolysosome | 11–11 11–12 |
Profilin Flagellin |
N/A | MyD88 | IL-12 |
TLR12 | Endolysosome | 12–11 12–12 |
Profilin | N/A | MyD88 | IL-12 |
TLR13 | Endolysosome | 13–13 | Bacterial 23S rRNA | ORN Sa19 | MyD88 | IL-12 |